InsiderFlow

Kristin Abate

KPTI

Kristin Abate serves as officer: Chief Accounting Officer at Karyopharm Therapeutics Inc. (KPTI). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

11 trades

$11.6K

Net Position

Net Seller

$11.6K

Companies Traded

1

KPTI

Active Period

Mar 2025 – Oct 2026

11 total trades

Most Recent

Sell KPTI

Oct 19, 2026 · $1.6K

Kristin Abate's Insider Trading at Karyopharm Therapeutics Inc. (KPTI)

Buys

0 · $0.00

Sells

11 · $11.6K

Total Shares Bought

0

Total Shares Sold

6,759

KPTI Price Chart
Loading chart...
DateTypeValue
Oct 19, 2026 Sell$1.6K
Oct 2, 2026 Sell$449.82
Sep 2, 2026 Sell$38.38
May 15, 2026 Sell$503.50
Jan 29, 2026 Sell$351.50
Jan 22, 2026 Sell$1.6K
Oct 3, 2025 Sell$2.3K
Sep 16, 2025 Sell$147.89
Sep 4, 2025 Sell$81.36
Jul 23, 2025 Sell$952.00
Mar 6, 2025 Sell$3.6K